A new score based on biomarker values to predict the prognosis of locally advanced cervical cancer.

CONCLUSION: This score includes three biomarkers with easily remembered cut-offs that allow us to identify, at the time of diagnosis, those patients with a high risk of relapse (scores of two or three) and those requiring dose escalation.
PMID: 32828580 [PubMed - as supplied by publisher]

Source: Gynecologic Oncology - August 18, 2020 Category: Cancer & Oncology Authors: Maulard A, Chargari C, Faron M, Alwohaibi A, Leary A, Pautier P, Genestie C, Morice P, Gouy S Tags: Gynecol Oncol Source Type: research